Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia

Biol Psychiatry. 1991 Oct 1;30(7):684-90. doi: 10.1016/0006-3223(91)90013-c.

Abstract

Circulating levels of dehydroepiandrosterone sulfate (DHEAS) and cortisol were studied in 86 patients with dementia; 45 with Alzheimer's disease and 41 with multi-infarct dementia. Compared to an elderly control group, after adjustment for age and sex, patients with Alzheimer's disease were found to have lower serum levels of DHEAS. We found a covariation between serum albumin and DHEAS levels, which may be of importance regarding peripheral hormone concentration in patients with dementia. These findings may provide evidence for a role of DHEAS in amnestic disorder in humans, either reflecting or contributing to the course of dementing diseases.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Alzheimer Disease / diagnosis*
  • Blood-Brain Barrier / physiology
  • Dehydroepiandrosterone / analogs & derivatives*
  • Dehydroepiandrosterone / blood
  • Dehydroepiandrosterone Sulfate
  • Dementia, Multi-Infarct / blood*
  • Dementia, Multi-Infarct / diagnosis*
  • Female
  • Humans
  • Hydrocortisone / blood
  • Male
  • Middle Aged
  • Nerve Degeneration / physiology
  • Neuropsychological Tests
  • Radioimmunoassay
  • Serum Albumin / metabolism

Substances

  • Serum Albumin
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone Sulfate
  • Hydrocortisone